Spinler SA - Search Results

1

Spinler SA, Mikhail PA. Spinler SA, et al. Ann Pharmacother. 1997 Nov;31(11):1339-46. doi: 10.1177/106002809703101112. Ann Pharmacother. 1997. PMID: 9391690 Review.

2

Propafenone-induced liver injury.

Spinler SA, Elder CA, Kindwall KE. Spinler SA, et al. Ann Pharmacother. 1992 Jul-Aug;26(7-8):926-8. doi: 10.1177/106002809202600714. Ann Pharmacother. 1992. PMID: 1354511

3

Nephrotoxicity of contrast media following cardiac angiography: pathogenesis, clinical course, and preventive measures, including the role of low-osmolality contrast media.

Spinler SA, Goldfarb S. Spinler SA, et al. Ann Pharmacother. 1992 Jan;26(1):56-64. doi: 10.1177/106002809202600113. Ann Pharmacother. 1992. PMID: 1606346 Review.

4

Upright tilt-table testing and drug therapy for recurrent vasovagal syncope.

Elder CA, Spinler SA. Elder CA, et al. Among authors: spinler sa. Ann Pharmacother. 1992 Jun;26(6):786-8. Ann Pharmacother. 1992. PMID: 1611163 No abstract available.

5

Should all patients with dilated cardiomyopathy receive chronic anticoagulation?

Cheng JW, Spinler SA. Cheng JW, et al. Among authors: spinler sa. Ann Pharmacother. 1994 May;28(5):604-9. doi: 10.1177/106002809402800510. Ann Pharmacother. 1994. PMID: 8069000 Review.

6

Prevention of anaphylactoid reactions in high-risk patients receiving radiographic contrast media.

Wittbrodt ET, Spinler SA. Wittbrodt ET, et al. Among authors: spinler sa. Ann Pharmacother. 1994 Feb;28(2):236-41. doi: 10.1177/106002809402800215. Ann Pharmacother. 1994. PMID: 8173143 Review.

7

Lipoprotein(A): physiologic function, association with atherosclerosis, and effects of lipid-lowering drug therapy.

Spinler SA, Cziraky MJ. Spinler SA, et al. Ann Pharmacother. 1994 Mar;28(3):343-51. doi: 10.1177/106002809402800310. Ann Pharmacother. 1994. PMID: 8193425 Review.

8

Propafenone-theophylline interaction.

Spinler SA, Gammaitoni A, Charland SL, Hurwitz J. Spinler SA, et al. Pharmacotherapy. 1993 Jan-Feb;13(1):68-71. Pharmacotherapy. 1993. PMID: 8437970

9

Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.

Hsu I, Spinler SA, Johnson NE. Hsu I, et al. Among authors: spinler sa. Ann Pharmacother. 1995 Jul-Aug;29(7-8):743-59. doi: 10.1177/106002809502907-818. Ann Pharmacother. 1995. PMID: 8520093 Review.

10

Antithrombotic therapy after intracoronary stenting.

Spinler S, Cheng J. Spinler S, et al. Pharmacotherapy. 1997 Jan-Feb;17(1):74-90. Pharmacotherapy. 1997. PMID: 9017767 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

152 results

Search Page